Francis C. C. Chow

1.4k total citations
28 papers, 1.1k citations indexed

About

Francis C. C. Chow is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Francis C. C. Chow has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Francis C. C. Chow's work include Diabetes Treatment and Management (13 papers), Diabetes Management and Research (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Francis C. C. Chow is often cited by papers focused on Diabetes Treatment and Management (13 papers), Diabetes Management and Research (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Francis C. C. Chow collaborates with scholars based in Hong Kong, China and United States. Francis C. C. Chow's co-authors include Andrea O. Y. Luk, Alice P.S. Kong, Juliana C.N. Chan, Wing‐Yee So, Eric S. H. Lau, Ronald C.W., David J. Nikolic‐Paterson, Robert C. Atkins, L Adhikary and Cosimo Stambe and has published in prestigious journals such as PLoS ONE, Diabetes Care and The American Journal of Medicine.

In The Last Decade

Francis C. C. Chow

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis C. C. Chow Hong Kong 14 765 369 247 118 117 28 1.1k
Francis Chun Chung Chow Hong Kong 11 661 0.9× 296 0.8× 187 0.8× 96 0.8× 115 1.0× 16 855
Marta Seghieri Italy 15 534 0.7× 246 0.7× 298 1.2× 125 1.1× 132 1.1× 26 852
Jun‐Sing Wang Taiwan 17 411 0.5× 226 0.6× 152 0.6× 138 1.2× 134 1.1× 93 1.0k
Fernando J. Lavalle‐González Mexico 17 948 1.2× 326 0.9× 374 1.5× 89 0.8× 258 2.2× 70 1.3k
P. T. Sawicki Germany 20 764 1.0× 414 1.1× 255 1.0× 117 1.0× 122 1.0× 46 1.4k
Cesare Berra Italy 16 530 0.7× 249 0.7× 197 0.8× 138 1.2× 116 1.0× 40 860
Kerensa Thorne United Kingdom 6 965 1.3× 239 0.6× 217 0.9× 102 0.9× 125 1.1× 13 1.4k
Irl B. Hirsch United States 7 746 1.0× 179 0.5× 206 0.8× 68 0.6× 75 0.6× 14 919
Sanbao Chai China 17 582 0.8× 289 0.8× 212 0.9× 135 1.1× 171 1.5× 49 935
Heidrun Bosch‐Traberg Denmark 14 1.2k 1.6× 462 1.3× 425 1.7× 172 1.5× 87 0.7× 25 1.5k

Countries citing papers authored by Francis C. C. Chow

Since Specialization
Citations

This map shows the geographic impact of Francis C. C. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis C. C. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis C. C. Chow more than expected).

Fields of papers citing papers by Francis C. C. Chow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis C. C. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis C. C. Chow. The network helps show where Francis C. C. Chow may publish in the future.

Co-authorship network of co-authors of Francis C. C. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Francis C. C. Chow. A scholar is included among the top collaborators of Francis C. C. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis C. C. Chow. Francis C. C. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Aroda, Vanita R., Andrew Ahmann, Bertrand Cariou, et al.. (2019). Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials. Diabetes & Metabolism. 45(5). 409–418. 191 indexed citations
3.
Luk, Andrea O. Y., Benny Zee, Ka Chun Chong, et al.. (2018). A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes. BMC Endocrine Disorders. 18(1). 59–59. 5 indexed citations
4.
Chan, Ruth, et al.. (2018). Diet quality is inversely associated with obesity in Chinese adults with type 2 diabetes. Nutrition Journal. 17(1). 63–63. 45 indexed citations
5.
Luk, Andrea O. Y., Eric S. H. Lau, Kitty Cheung, et al.. (2017). Glycaemia control and the risk of hospitalisation for infection in patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetes/Metabolism Research and Reviews. 33(8). 18 indexed citations
6.
Leiter, Lawrence A., Jorge Luiz Gross, Francis C. C. Chow, et al.. (2017). Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus: Results over 52 weeks. Journal of Diabetes and its Complications. 31(8). 1283–1285. 10 indexed citations
7.
Chan, Ruth, et al.. (2017). High Hedonic Hunger and Unhealthy Dietary Behaviors are Associated with Central Obesity among Chinese Adults with Type 2 Diabetes. Journal of the Academy of Nutrition and Dietetics. 117(9). A26–A26. 1 indexed citations
8.
Cheung, Kitty, Guozhi Jiang, Jenny S. W. Lee, et al.. (2016). Modifying Effect of Body Mass Index on Survival in Elderly Type 2 Diabetic Patients: Hong Kong Diabetes Registry. Journal of the American Medical Directors Association. 17(3). 276.e15–276.e22. 9 indexed citations
9.
Chan, Doris, Andrea O. Y. Luk, Wing Yee So, et al.. (2016). Natural history and outcome in chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis. BMC Endocrine Disorders. 16(1). 12–12. 11 indexed citations
10.
Chow, Francis C. C., et al.. (2016). A clinical study of the anti-diabetic effect of a simple Chinese herbal formula, PSP-1. European Journal of Integrative Medicine. 8(4). 458–464. 1 indexed citations
11.
Luk, Andrea O. Y., Eric S. H. Lau, Gary T.C. Ko, et al.. (2016). Association of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes. Medicine. 95(45). e5183–e5183. 13 indexed citations
12.
Luk, Andrea O. Y., Xue Li, Risa Ozaki, et al.. (2015). The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes. PLoS ONE. 10(8). e0134981–e0134981. 25 indexed citations
13.
Chan, Juliana C.N., Eric S. H. Lau, Andrea O. Y. Luk, et al.. (2014). Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis. The American Journal of Medicine. 127(7). 616–624. 107 indexed citations
14.
Chan, Juliana C.N., Risa Ozaki, Andrea O. Y. Luk, et al.. (2014). Delivery of integrated diabetes care using logistics and information technology – The Joint Asia Diabetes Evaluation (JADE) program. Diabetes Research and Clinical Practice. 106. S295–S304. 19 indexed citations
15.
Kaneko, Shizuka, Francis C. C. Chow, Dong Seop Choi, et al.. (2014). Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial. Diabetes Research and Clinical Practice. 107(1). 139–147. 66 indexed citations
16.
Luk, Andrea O. Y., Ronald C.W., Eric S. H. Lau, et al.. (2013). Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes/Metabolism Research and Reviews. 29(5). 384–390. 117 indexed citations
17.
Hewitson, Tim D., et al.. (2011). Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease. Nephrology Dialysis Transplantation. 27(3). 906–912. 24 indexed citations
18.
Luk, Andrea O. Y., Xilin Yang, Ronald C.W., et al.. (2010). Association of statin use and development of renal dysfunction in type 2 diabetes—The Hong Kong Diabetes Registry. Diabetes Research and Clinical Practice. 88(3). 227–233. 17 indexed citations
19.
Adhikary, L, Francis C. C. Chow, David J. Nikolic‐Paterson, et al.. (2004). Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia. 47(7). 1210–1222. 175 indexed citations
20.
King, Ann D., Francis C. C. Chow, Anil T. Ahuja, & Polly Richards. (2002). Thyrotoxic Periodic Paralysis: Sonographic appearances of the thyroid. Journal of Clinical Ultrasound. 30(9). 544–547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026